Latest Breaking News On - First line azacytidine - Page 1 : comparemela.com

Pulling data from a US electronic health record–based database, researchers found low rates of complete remission and poor overall survival among 382 patients who had myelodysplastic syndromes (MDS) receiving first-line azacytidine (AZA).

Eastern cooperative oncology groupClinical lymphomaMyelodysplastic syndromesFirst line azacytidine